CollPlant Biotechnologies Ltd. (CLGN) vs 60 Degrees Pharmaceuticals, Inc. (SXTP)
A side-by-side comparison of CollPlant Biotechnologies Ltd. and 60 Degrees Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLGN
CollPlant Biotechnologies Ltd.
$3.35HealthcareDelayed quote: Oct 6, 2026, 1:52 PM EDT
SXTP
60 Degrees Pharmaceuticals, Inc.
$1.18HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — CLGN vs SXTP
growth of $100 · dividends reinvested · last 3yCLGN -95.5% (-64.4%/yr)SXTP -99.9% (-89.1%/yr)CLGN compounded faster over this window
Log scale — wide-divergence pair
CLGN SXTP
CLGN vs SXTP: by the numbers
- •CLGN is the larger company ($4M vs $4M market cap).
- •Both run net losses; SXTP's is the smaller (-730.23% vs -3934.91% net margin).
- •Both shrank revenue over the past five years; SXTP's decline was smaller (-14.35% vs -56.28% CAGR).
Metrics side by side
Valuation
| Metric | CLGN | SXTP |
|---|---|---|
| P/S ratio | 13.66 | 3.74 |
| P/B ratio | 1.47 | N/A |
Profitability
| Metric | CLGN | SXTP |
|---|---|---|
| Gross margin | 26.32% | 19.42% |
| Operating margin | -484.31% | -774.90% |
| Net margin | -3934.91% | -730.23% |
| ROE | -424.89% | -310.33% |
| ROIC | -221.32% | -321.28% |
Growth (annualized)
| Metric | CLGN | SXTP |
|---|---|---|
| Revenue CAGR (5Y) | -56.28% | -14.35% |
| Total return CAGR (5Y) | -53.69% | N/A |
Frequently asked
- Which has grown faster, CLGN or SXTP?
- Neither grew: over the past five years both shrank revenue, with SXTP's decline the smaller — CLGN at a -56.28% CAGR versus SXTP at -14.35%.
Go deeper
Dig into the metrics
CollPlant Biotechnologies ROE60 Degrees Pharmaceuticals ROECollPlant Biotechnologies operating margin60 Degrees Pharmaceuticals operating marginCollPlant Biotechnologies revenue growth60 Degrees Pharmaceuticals revenue growthCollPlant Biotechnologies free cash flow60 Degrees Pharmaceuticals free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.